Germany · Delayed Price · Currency is EUR Merck KGaA Statistics
Total Valuation
Merck KGaA has a market cap or net worth of EUR 47.89 billion. The enterprise value is 56.59 billion.
| Market Cap | 47.89B |
| Enterprise Value | 56.59B |
Important Dates
The last earnings date was Thursday, March 5, 2026.
| Earnings Date | Mar 5, 2026 |
| Ex-Dividend Date | Apr 28, 2025 |
Share Statistics
Merck KGaA has 434.78 million shares outstanding.
| Current Share Class | 129.24M |
| Shares Outstanding | 434.78M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | -0.22% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 16.54% |
| Float | 129.24M |
Valuation Ratios
The trailing PE ratio is 18.36 and the forward PE ratio is 13.88. Merck KGaA's PEG ratio is 1.97.
| PE Ratio | 18.36 |
| Forward PE | 13.88 |
| PS Ratio | 2.27 |
| PB Ratio | 1.67 |
| P/TBV Ratio | 15.97 |
| P/FCF Ratio | 20.41 |
| P/OCF Ratio | 12.18 |
| PEG Ratio | 1.97 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.93, with an EV/FCF ratio of 24.11.
| EV / Earnings | 21.70 |
| EV / Sales | 2.68 |
| EV / EBITDA | 9.93 |
| EV / EBIT | 14.40 |
| EV / FCF | 24.11 |
Financial Position
The company has a current ratio of 1.46, with a Debt / Equity ratio of 0.42.
| Current Ratio | 1.46 |
| Quick Ratio | 0.90 |
| Debt / Equity | 0.42 |
| Debt / EBITDA | 2.10 |
| Debt / FCF | 5.10 |
| Interest Coverage | 12.06 |
Financial Efficiency
Return on equity (ROE) is 8.92% and return on invested capital (ROIC) is 8.23%.
| Return on Equity (ROE) | 8.92% |
| Return on Assets (ROA) | 4.76% |
| Return on Invested Capital (ROIC) | 8.23% |
| Return on Capital Employed (ROCE) | 9.25% |
| Weighted Average Cost of Capital (WACC) | 7.00% |
| Revenue Per Employee | 357,195 |
| Profits Per Employee | 44,146 |
| Employee Count | 62,346 |
| Asset Turnover | 0.41 |
| Inventory Turnover | 1.92 |
Taxes
In the past 12 months, Merck KGaA has paid 693.00 million in taxes.
| Income Tax | 693.00M |
| Effective Tax Rate | 20.95% |
Stock Price Statistics
The stock price has decreased by -19.66% in the last 52 weeks. The beta is 0.72, so Merck KGaA's price volatility has been lower than the market average.
| Beta (5Y) | 0.72 |
| 52-Week Price Change | -19.66% |
| 50-Day Moving Average | 125.25 |
| 200-Day Moving Average | 115.87 |
| Relative Strength Index (RSI) | 26.65 |
| Average Volume (20 Days) | 317,388 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Merck KGaA had revenue of EUR 21.10 billion and earned 2.61 billion in profits. Earnings per share was 6.00.
| Revenue | 21.10B |
| Gross Profit | 12.43B |
| Operating Income | 3.93B |
| Pretax Income | 3.31B |
| Net Income | 2.61B |
| EBITDA | 5.70B |
| EBIT | 3.93B |
| Earnings Per Share (EPS) | 6.00 |
Balance Sheet
The company has 3.34 billion in cash and 11.97 billion in debt, with a net cash position of -8.63 billion or -19.85 per share.
| Cash & Cash Equivalents | 3.34B |
| Total Debt | 11.97B |
| Net Cash | -8.63B |
| Net Cash Per Share | -19.85 |
| Equity (Book Value) | 28.66B |
| Book Value Per Share | 65.76 |
| Working Capital | 4.19B |
Cash Flow
In the last 12 months, operating cash flow was 3.93 billion and capital expenditures -1.59 billion, giving a free cash flow of 2.35 billion.
| Operating Cash Flow | 3.93B |
| Capital Expenditures | -1.59B |
| Free Cash Flow | 2.35B |
| FCF Per Share | 5.40 |
Margins
Gross margin is 58.90%, with operating and profit margins of 18.62% and 12.36%.
| Gross Margin | 58.90% |
| Operating Margin | 18.62% |
| Pretax Margin | 15.68% |
| Profit Margin | 12.36% |
| EBITDA Margin | 27.01% |
| EBIT Margin | 18.62% |
| FCF Margin | 11.12% |
Dividends & Yields
This stock pays an annual dividend of 2.20, which amounts to a dividend yield of 2.00%.
| Dividend Per Share | 2.20 |
| Dividend Yield | 2.00% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 36.68% |
| Buyback Yield | n/a |
| Shareholder Yield | 2.00% |
| Earnings Yield | 5.45% |
| FCF Yield | 4.90% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on June 30, 2014. It was a forward split with a ratio of 2.
| Last Split Date | Jun 30, 2014 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
Merck KGaA has an Altman Z-Score of 2.78 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.78 |
| Piotroski F-Score | 5 |